Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01916447
Title A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors.
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Taiho Oncology, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Los Angeles Clinical Site Los Angeles California 90095 United States Details
Chicago Clinical Site Chicago Illinois 60611 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
Vanderbilt Ingram Cancer Center Nashville Tennessee 37212 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field